RAD51 and neoplasm: Cells with reduced dormant origins are therefore extremely sensitive to DNA damaging agents56,57 while still capable of forming RAD51 foci58, which is in line with the RAD51 positive phenotype of this cisplatin-sensitive tumour (PDX T302).